Our mission at Erasca is embedded in our name: To erase cancer.
Energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. We have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals.
In addition to our initial programs for undisclosed cancer targets, we seek to expand our pipeline through partnerships with academic scientists and biopharmaceutical companies who have revealed potential new mechanisms for precision oncology. Importantly, Erasca isn’t tied to one form of drug or any singular approach to treating cancer. By keeping an open mind about what is possible, we believe we will achieve the greatest results for patients everywhere.
Location: Mali, Ségou
Employees: 51-200
Total raised: $542M
Founded date: 2018
Investors 5
| Date | Name | Website |
| - | PFM Health... | pfmhealths... |
| - | Terra Magn... | terramagnu... |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | a16z | a16z.com/ |
| - | LifeSci Ve... | lifesciven... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 01.09.2020 | Series B | $236M | - |
| 12.05.2020 | Series B | $200M | - |
| 05.03.2019 | - | $64M | - |
| 18.12.2018 | Series A | $42M | - |
Mentions in press and media 34
| Date | Title | Description | Source |
| 27.03.2024 | Erasca Announces $45 Million Oversubscribed Private Placemen... | - | globenewsw... |
| 12.07.2021 | Erasca, Inc. Prices IPO | Erasca, Inc. announced the initial public offering of 17,500,000 shares of its common stock on July ... | sdbj.com/n... |
| 01.09.2020 | Erasca raises an additional $36 million in Series B funding ... | Erasca, a San Diego, Californa-based biotech startup that has its mission embedded in its name (eras... | techstartu... |
| 01.09.2020 | Erasca Completes $36M Extension of Series B Financing | Erasca, a San Diego, CA-based cancer therapeutics company, completed a $36m extension of its Series ... | finsmes.co... |
| 31.08.2020 | Erasca Brings In $36M More For Series B For Cancer Treatment... | 11 Shares Email Facebook Twitter LinkedIn Erasca, creating oncology drugs intended to provide precis... | news.crunc... |
| 31.08.2020 | Erasca Brings In $36M More For Series B For Cancer Treatment... | 12 Shares Email Facebook Twitter LinkedIn Erasca, creating oncology drugs intended to provide precis... | news.crunc... |
| 31.08.2020 | Erasca has announced raising an additional $36M, bringing it... | - | connect.or... |
| 31.08.2020 | Erasca Snares $36M Series B Extension | SAN DIEGO, CA, Erasca announced the completion of a $36 million extension of its Series B financin... | vcnewsdail... |
| 31.08.2020 | Erasca : Extends Series B Financing to $236 Million | Erasca, a company whose mission is to erase cancer, today announced the completion of a $36 million ... | marketscre... |
| 31.08.2020 | Erasca Extends Series B Financing to $236 Million | SAN DIEGO--(BUSINESS WIRE)--Erasca, a company whose mission is to erase cancer, today announced the ... | archive.ci... |
Show more